FundedIQ
Biotechnology

Starkage Therapeutics: Funding, Investors & Team (Sep 2026)

Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.

starkagetx.com LinkedIn Lille, France 1-10 employees
Total raised
$2.3M
Rounds
1
Latest
Undisclosed round
Jan 2022

Starkage Therapeutics has raised $2.3M across 1 funding round on record, the most recent an undisclosed round of $2.3M announced in Jan 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Starkage Therapeutics Company Profile and Key Stats

Total funding raised
$2.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.3M in Jan 2022
Employees
1-10
reported band
Headquarters
Lille, France

Latest funding round on record: Jan 2022.

Starkage Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$2.3M

Starkage Therapeutics Founders and Leadership Team

Name
Role
Contact
Thierry Mathieu
CEO

No contact details are on record for this team yet.

Starkage Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
1,705
$6.7M

Starkage Therapeutics' latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Starkage Therapeutics in Biotechnology and Lille

Companies Similar to Starkage Therapeutics

Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…

Series A $12.6M

TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…

Series D $34.0M

NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…

Undisclosed round $6.9M

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…

Undisclosed round $1.7M

One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…

Undisclosed round

Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…

Undisclosed round $120M

NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…

Undisclosed round $8.4M

AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…

Undisclosed round $11.6M

Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…

Undisclosed round $116M

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…

Undisclosed round $7.0M

Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…

Undisclosed round $45.0M

AB Science was established in 2001 by a group of individuals in the medical and business fields who are…

Undisclosed round $3.7M

Starkage Therapeutics Funding FAQs

What does Starkage Therapeutics do?

Starkage Therapeutics is a biotechnology company that aims to delay and improve quality of life of patients with age-related diseases.

How much funding has Starkage Therapeutics raised?

Starkage Therapeutics has raised $2.3M across 1 round on record. The most recent is an undisclosed round of $2.3M announced in Jan 2022.

When did Starkage Therapeutics last raise funding?

Starkage Therapeutics' most recent funding round on record is an undisclosed round of $2.3M, announced in Jan 2022.

Who is the CEO of Starkage Therapeutics?

Thierry Mathieu is listed as CEO at Starkage Therapeutics.

Where is Starkage Therapeutics headquartered?

Starkage Therapeutics is based in Lille, Nord-Pas-De-Calais, France.

How many employees does Starkage Therapeutics have?

Starkage Therapeutics is in the 1-10 employee band.

How does Starkage Therapeutics' funding compare to other Biotechnology startups?

Starkage Therapeutics' latest round of $2.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Starkage Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Starkage Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.